Methionyl-tRNA Synthetase is a Useful Diagnostic Marker for Lymph Node Metastasis in Non-Small Cell Lung Cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Identification of lymph node (LN) metastasis in non-small cell lung cancer (NSCLC) is critical for disease staging and selectionof therapeutic modalities. Sometimes it is not possible to obtain LN core tissue by endobronchial ultrasound-guided transbronchialneedle aspirate (EBUS-TBNA), resulting in low diagnostic yield. Materials and Methods: In this study, 138 specimens were collected from 108 patients who underwent EBUS-TBNA under thesuspicion of LN metastasis of NSCLC. Diagnostic yields of anti-CD45 and anti-methionyl-tRNA synthetase (MRS), immunofluorescent(IF) staining on cytology specimens were compared with those of conventional cytology and positron emission tomography-computed tomography (PET-CT). Results: MRS was strongly expressed in NSCLC cells metastasized to LNs, but weakly expressed in cells at the periphery of the LNgerminal center. The majority of cells were CD20 positive, although a few cells were either CD3 or CD14 positive, indicating thatCD45 staining is required for discrimination of non-malignant LN constituent cells from NSCLC cells. When the diagnostic efficacyof MRS/CD45 IF staining was evaluated using 138 LN cellular aspirates from 108 patients through EBUS-TBNA, the sensitivity was76.7% and specificity was 90.8%, whereas those of conventional cytology test were 71.8% and 100.0%, respectively. Combining theresults of conventional cytology testing and those of PET-CT showed a sensitivity and specificity of 71.6% and 100%, and the additionof MRS/CD45 dual IF data to this combination increased sensitivity and specificity to 85.1% and 97.8%, respectively. Conclusion: MRS/CD45 dual IF staining showed good diagnostic performance and may be a good tool complementing conventionalcytology test for determining LN metastasis of NSCLC.
Abstract
Purpose: Identification of lymph node (LN) metastasis in non-small cell lung cancer (NSCLC) is critical for disease staging and selectionof therapeutic modalities. Sometimes it is not possible to obtain LN core tissue by endobronchial ultrasound-guided transbronchialneedle aspirate (EBUS-TBNA), resulting in low diagnostic yield. Materials and Methods: In this study, 138 specimens were collected from 108 patients who underwent EBUS-TBNA under thesuspicion of LN metastasis of NSCLC. Diagnostic yields of anti-CD45 and anti-methionyl-tRNA synthetase (MRS), immunofluorescent(IF) staining on cytology specimens were compared with those of conventional cytology and positron emission tomography-computed tomography (PET-CT). Results: MRS was strongly expressed in NSCLC cells metastasized to LNs, but weakly expressed in cells at the periphery of the LNgerminal center. The majority of cells were CD20 positive, although a few cells were either CD3 or CD14 positive, indicating thatCD45 staining is required for discrimination of non-malignant LN constituent cells from NSCLC cells. When the diagnostic efficacyof MRS/CD45 IF staining was evaluated using 138 LN cellular aspirates from 108 patients through EBUS-TBNA, the sensitivity was76.7% and specificity was 90.8%, whereas those of conventional cytology test were 71.8% and 100.0%, respectively. Combining theresults of conventional cytology testing and those of PET-CT showed a sensitivity and specificity of 71.6% and 100%, and the additionof MRS/CD45 dual IF data to this combination increased sensitivity and specificity to 85.1% and 97.8%, respectively. Conclusion: MRS/CD45 dual IF staining showed good diagnostic performance and may be a good tool complementing conventionalcytology test for determining LN metastasis of NSCLC.
참고문헌 (25)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)
- Siegel RL, "Cancer statistics, 2017", CA Cancer J Clin, 67, pp.7~30 (2017)
- National Lung Screening Trial Research Team, "Reduced lung-cancer mortality with low-dose computed tomographic screening", N Engl J Med, 365, pp.395~409 (2011)
- Horeweg N, "Lung cancer probability in patients with CT-detected pulmonary nodules : a prespecified analysis of data from the NELSON trial of low-dose CT screening", Lancet Oncol, 15, pp.1332~1341 (2014)
- Infante M, "Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography", Am J Respir Crit Care Med, 191, pp.1166~1175 (2015)
- Aberle DR, "Computed tomography screening for lung cancer : has it finally arrived? Implications of the national lung screening trial", J Clin Oncol, 31, pp.1002~1008 (2013)
- Evison M, "Nodal staging in lung cancer : a risk stratification model for lymph nodes classified as negative by EBUS-TBNA", J Thorac Oncol, 10, pp.126~133 (2015)
- Trisolini R, "Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping", Chest, 148, pp.1430~1437 (2015)
- Bonifazi M, "The role of the pulmonologist in rapid on-site cytologic evaluation of transbronchial needle aspiration : a prospective study", Chest, 145, pp.60~65 (2014)
- Kim S, "Aminoacyl-tRNA synthetases and tumorigenesis : more than housekeeping", Nat Rev Cancer, 11, pp.708~718 (2011)
- Han JM, "Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway", Cell, 149, pp.410~424 (2012)
- Yannay-Cohen N, "LysRS serves as a key signaling molecule in the immune response by regulating gene expression", Mol Cell, 34, pp.603~611 (2009)
- Keller TL, "Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase", Nat Chem Biol, 8, pp.311~317 (2012)
- Kim EY, "Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer", BMC Cancer, 17, pp.467~ (2017)
- Kim JH, "Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction", Nat Commun, 8, pp.732~ (2017)
- Kwon NH, "Dual role of methionyl-tRNA synthetase in the regulation of translation and tumor suppressor activity of aminoacyl-tRNA synthetase-interacting multifunctional protein-3", Proc Natl Acad Sci U S A, 108, pp.19635~19640 (2011)
- Dehm SM, "mRNA splicing variants : exploiting modularity to outwit cancer therapy", Cancer Res, 73, pp.5309~5314 (2013)
- Um SW, "Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer", J Thorac Oncol, 10, pp.331~337 (2015)
- Nayak A, "Endobronchial ultrasound-guided transbronchial needle aspirate(EBUS-TBNA) : a proposal for on-site adequacy criteria", Diagn Cytopathol, 40, pp.128~137 (2012)
- Alsharif M, "Endobronchial ultrasound-guided transbronchial fine-needle aspiration : the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties", Am J Clin Pathol, 130, pp.434~443 (2008)
- Hadchouel A, "Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island", Am J Hum Genet, 96, pp.826~831 (2015)
- Sun Y, "Mutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia", J Hum Genet, 62, pp.647~651 (2017)
- Mallya V, "The utility of ROSE (rapid on-site evaluation) in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA):is the picture rosy?", J Cytol, 32, pp.230~233 (2015)
- Lee TK, "size of small cell lung carcinoma cells. Ratio to lymphocytes and correlation with specimen size and crush artifact", Anal Quant Cytol Histol, 14, pp.32~34 (1992)
- Schmid C, "Expression of B-cell antigens by Hodgkin’s and Reed-Sternberg cells", Am J Pathol, 139, pp.701~707 (1991)